The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. - Test2 - elhamkhani - TriplyDB

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

http://www.wikidata.org/entity/Q34211073

about

The detection, treatment, and biology of epithelial ovarian cancer WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung Human epididymis protein-4 (HE-4): a novel cross-class protease inhibitor Lung cancer signatures in plasma based on proteome profiling of mouse tumor models HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Beyond CA125: the coming of age of ovarian cancer biomarkers In 2014, can we do better than CA125 in the early detection of ovarian cancer?The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Proteomics of ovarian cancer: functional insights and clinical applications Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.Global gene expression profiling in human lung cells exposed to cobalt.A mouse to human search for plasma proteome changes associated with pancreatic tumor development.Systematic evaluation of candidate blood markers for detecting ovarian cancer.Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses.Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study Use of a single-chain antibody library for ovarian cancer biomarker discovery.Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress Development of a multimarker assay for early detection of ovarian cancer.Proteomic cancer biomarkers from discovery to approval: it's worth the effort Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk women CA125 in ovarian cancer Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases.Early detection of ovarian cancer Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review.Novel translational strategies in colorectal cancer research.Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.HE4 as a biomarker for ovarian and endometrial cancer management.

P2860

Q21198791-BEC81B6F-140B-48E2-8AB6-9220F156930A Q21284411-E465AFEF-6C00-4C47-9F4A-DF589D0F26D0 Q24303274-7B4C1916-F8BF-4DF2-9B6C-98333AE39E05 Q24628852-1902F8EF-B46F-478E-807C-A5506D8870F7 Q24634978-2CCED9CA-B6E3-4239-8D07-735EE64E0852 Q24651331-2939DEFF-E53A-49A8-9FF8-119996AEC218 Q24651567-68F503EF-B9D1-401D-B84C-1F63103DC410 Q26825152-2CAA5720-8300-4F5D-A998-F0672A1D7F84 Q26992102-F6710388-1E5B-4450-A68B-938138F0DCF6 Q28082632-AA26BAFB-0917-476C-B426-87DD6D5F6DA1 Q28748985-7FAA4A26-0439-40BE-B02E-8E9D78967AEE Q30414041-FCD7C931-BA68-48F1-B290-7CBFB958A7B8 Q30449569-C52557B3-88B7-44DE-8875-6A810B7EB7BF Q30597866-3AB7042F-3A19-4C02-BE11-D6244B0C4FB9 Q30914170-606370C0-5CF7-4BE9-BCC4-02C254F1345A Q33286948-FFD7F822-8CB4-436D-9253-01E914D307DE Q33343004-DC30AA98-0770-4DF7-AF77-ECC6383B3501 Q33350146-1689583E-6D90-4E2C-95D2-0BD1A85592A1 Q33484414-4F9E0246-CE90-4E28-AE0F-D57A871000A2 Q33533979-2A95083E-C1F1-461F-ADFF-4E7638592DA6 Q33572029-FBF732B8-CA37-4639-A272-EFBE76AC5297 Q33574039-C858D508-8EE1-45E9-B27E-5C5BFDD634BE Q33577786-E41670B2-5E67-4009-94ED-3700034F3C34 Q33622587-0D4872A0-C9FC-4F60-9EAC-C13855BFB12F Q33653799-6B1A9EFF-AEE6-4C74-85AA-A0C486F09C13 Q33690390-1C2EFD51-441F-4110-98F6-ACDCD73AA7FD Q33713506-B56CE4B6-03D4-4BFB-BC69-F336423AD4D1 Q33813724-F2BF3754-DBC1-4C36-9C1A-273827B86BFF Q33836290-8DA92ECC-4C46-41AF-9B66-E65F60DD980A Q33848119-4D1D953A-D7C1-4EE7-819C-4CD8B934EF01 Q33859857-0440AE6F-66E4-4AA4-BB66-E8F1255F6278 Q33915144-2037E473-A872-419A-9AC8-0D4276475C23 Q33955266-79B388C8-B7AD-4EE1-8952-7F506E0BF48B Q34092935-D4D100F6-A99A-45B5-8798-36AD3172C1F8 Q34094731-3FD82A6A-529D-449B-B4EC-CF8B8505B909 Q34308808-1CA5E9A0-C84B-42BB-ADE9-CF020CD3DCA0 Q34370883-EEE24102-8394-4FBB-BB23-CAD3A75079A6 Q34382804-DFB9A169-FCB5-4B2E-9186-F4D2A06307D6 Q34384802-79E19B83-C230-4113-9B82-3F362B4D2F65 Q34611530-FB809B68-5713-4915-AA15-7670D24AEDE7

P2860

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

http://www.wikidata.org/entity/Q34211073

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

@ast

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

@en

The HE4

@nl

type

label

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

@ast

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

@en

The HE4

@nl

prefLabel

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

@ast

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

@en

The HE4

@nl

P1433

Q34211073-582F8CAE-674D-4B46-AA0C-26C7D0EB7C12

P1476

Q34211073-8B4C9AFC-F121-422B-9705-7605F3AD532E

P2093

Q34211073-0E65DDEB-A3C4-4F3A-AD84-0FE59631E653

Q34211073-24A0A878-1F28-4427-9132-BC995871B6D9

Q34211073-402FA8A2-CB92-42C9-88A5-30ECF0E05E89

Q34211073-A731DE23-468C-4DBF-B430-586322317CD9

Q34211073-C56C1BAB-D64E-4EEA-B4BE-778F48AD1FD9

Q34211073-DA914D96-7B4E-476E-B8B8-56A447D0BD9F

Q34211073-E20399D3-24E0-4E2C-B1FE-58F7DCFF4311

Q34211073-E40055B1-24F6-487C-84A4-62B734A8AE36

Q34211073-F58A5E53-BA5A-4378-93C0-1B9C3B0F3E4F

P304

Q34211073-30956BD2-03EF-4E60-8279-A4FA62B6812F

P31

Q34211073-0C4E163A-BC65-40BF-8B7F-5246354DDB7E

P407

Q34211073-FAB12AE7-AE32-433F-A8E3-BC6D49B67D95

P433

Q34211073-ED38DD8B-DDA7-4320-BD0D-DA546F2B8D15

P478

Q34211073-BE2E5430-A0AF-4B33-B9CE-C043D97B3920

P577

Q34211073-D3D0EF07-5D52-477A-B493-92EBE5302016

P698

Q34211073-88BA0430-D4EE-448A-A94E-51B0AA5D71A5

P921

Q34211073-BB8B0D14-8E6F-4DFE-A4F3-932F9CF04FD0

P1433

Cancer Research

P1476

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma

@en

P2093

Charles Drescher

http://www.w3.org/2001/XMLSchema#string

Ingegerd Hellström

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Ledbetter

http://www.w3.org/2001/XMLSchema#string

John Raycraft

http://www.w3.org/2001/XMLSchema#string

Karl Erik Hellström

http://www.w3.org/2001/XMLSchema#string

Martha Hayden-Ledbetter

http://www.w3.org/2001/XMLSchema#string

Martin McIntosh

http://www.w3.org/2001/XMLSchema#string

Michèl Schummer

http://www.w3.org/2001/XMLSchema#string

Nicole Urban

http://www.w3.org/2001/XMLSchema#string

P304

3695-3700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12839961

http://www.w3.org/2001/XMLSchema#string

P921